| Keyword | CPC | PCC | Volume | Score | Length of keyword |
|---|---|---|---|---|---|
| csl limited ceo | 1.49 | 0.4 | 9091 | 1 | 15 |
| csl | 1.45 | 0.7 | 7558 | 48 | 3 |
| limited | 1.2 | 0.7 | 3187 | 67 | 7 |
| ceo | 0.54 | 0.6 | 650 | 7 | 3 |
| Keyword | CPC | PCC | Volume | Score |
|---|---|---|---|---|
| csl limited ceo | 1.72 | 1 | 2415 | 95 |
Director of CSL Limited since February 2013, and appointed Chief Executive Officer and Managing Director in July 2013. Mr Perreault has more than 35 years of experience across both the global biotech and pharmaceutical industries.
When did Paul Perreault become CEO of CSL?He was appointed Chief Executive Officer and Managing Director of CSL Limited in July 2013, and was appointed to the CSL Board of Directors the same year. Since then, CSL has grown to become the third largest biotech company in the world with more than 27,000 employees bringing lifesaving medicines to people in more than 100 countries.
Who is the CEO of CSL Behring Australia?Additionally, the influential Australian Financial Review named Paul its 2017 CEO of the Year and, in 2016, Paul was awarded Healthcare CEO of the Year from the Philadelphia Alliance for Capital and Technologies.
When did Brian McNamee become CEO of CSL?Dr McNamee has a broad global perspective and understanding of long-term capital projects in the pharmaceutical industry, with proven health, safety, environment and corporate responsibility. Dr McNamee was the Chief Executive Officer and Managing Director of CSL from 1990 until 2013.
